Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response

INTRODUCTION: In registration trials, triple therapy with telaprevir (TVR), pegylated-interferon (IFN), and ribavirin (RBV) achieved sustained virological response (SVR) rates between 64–75%, but the clinical effectiveness and economic burdens of this treatment in real-world practice remain to be de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bichoupan, Kian, Martel-Laferriere, Valerie, Sachs, David, Ng, Michel, Schonfeld, Emily A., Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Perumalswami, Ponni V., Schiano, Thomas D., Odin, Joseph A., Liu, Lawrence, Moskowitz, Alan J., Dieterich, Douglas T., Branch, Andrea D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190678/
https://ncbi.nlm.nih.gov/pubmed/25065814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados